| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |